TRPM4 and stroke disorder: Antidiabetic treatments can cause GI effects, nausea, bloating, weight gain. (Beltrand et al., 2019) SUR1 regulatory subunit also interacts with TRPM4, with this interaction being suggested as a therapeutic target in stroke (Koivisto et al., 2022)